Physician profile
Mariam Rabiu
NPI 1821847559
$1,383.38
in general payments reported to CMS, 2019-2025
9 companies · $879 in 2025
The $879 reported for 2025 was more than what 93% of Registered Nurse providers received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $504 · 2025: $879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,383.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $445.61 | 2024-2025 | Livdelzi, Vemlidy, Epclusa |
| Corcept Therapeutics | $206.12 | 2025 | Korlym |
| Paratek Pharmaceuticals, INC. | $124.98 | 2025 | Nuzyra |
| Kyowa Kirin, INC. | $123.16 | 2024 | |
| Alexion Pharmaceuticals, INC. | $121.82 | 2025 | |
| Viiv Healthcare Company | $118.63 | 2025 | |
| Abbvie INC. | $118.23 | 2025 | |
| Galderma Laboratories, L.P. | $67.72 | 2025 | |
| Coloplast Corp | $57.11 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariam Rabiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.